Related Experiment Video
Updated: Jan 6, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
ZNF703 is an important player in head and neck cancer
Ceren Orhan1, Burak Bakır1, Nejat Dalay1
1Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Objectives:
Despite advances in treatment, head and neck squamous cell carcinoma (HNSCC) remains difficult to treat and the overall survival rate has only modestly improved over the past years. Therefore, there is a need to understand the molecular mechanism of HNSCC. Zinc finger protein 703 (ZNF703) is an oncogenic transcription factor, and ZNF703 gene expression is altered in many cancers as a result of chromosome 8p12 amplification. The purpose of this study was to investigate the expression pattern of ZNF703 in HNSCC in association with CCND1 expression and Akt phosphorylation.
Design:
Prospective study.
Setting:
University hospital.
Participants:
One hundred and five patients with HNSCC.
Methods:
Fifty HNSCC tumour and non-cancerous tissue samples were investigated by qRT-PCR and Western blotting.
Results:
ZNF703 gene expression was increased in 22.9% of tumour tissues compared with its normal counterparts. The results were correlated with clinicopathological features, copy number variation and survival data.
Conclusion:
ZNF703 over-expression is associated with copy number variation and this over-expression may activate PI3K/Akt signalling pathway in HNSCC.
Insights
Head and neck squamous cell carcinoma (HNSCC) shows increased Zinc finger protein 703 (ZNF703) expression, linked to gene amplification. This over-expression may activate the PI3K/Akt pathway, offering new therapeutic targets for HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) presents significant treatment challenges with limited survival improvements.
- Understanding the molecular underpinnings of HNSCC is crucial for developing effective therapies.
- Zinc finger protein 703 (ZNF703) is an oncogenic transcription factor implicated in various cancers due to chromosome 8p12 amplification.
Purpose of the Study:
- To investigate the expression patterns of ZNF703 in HNSCC.
- To analyze the association between ZNF703 expression, CCND1 expression, and Akt phosphorylation in HNSCC.
- To explore the molecular mechanisms driving HNSCC development and progression.
Main Methods:
- Prospective study involving 105 HNSCC patients.
- Analysis of 50 HNSCC tumor and non-cancerous tissue samples using qRT-PCR and Western blotting.
- Correlation of ZNF703 expression with clinicopathological features, copy number variation, and survival data.
Main Results:
- ZNF703 gene expression was elevated in 22.9% of HNSCC tumor tissues compared to normal counterparts.
- ZNF703 over-expression was found to be associated with copy number variation.
- Preliminary findings suggest a link between ZNF703 over-expression and the activation of the PI3K/Akt signaling pathway.
Conclusions:
- ZNF703 over-expression is linked to copy number variations in HNSCC.
- The over-expression of ZNF703 may contribute to HNSCC pathogenesis by activating the PI3K/Akt signaling pathway.
- Further research into ZNF703's role could reveal novel therapeutic strategies for HNSCC.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

